Nine More Drugmakers Just Signed On to Lower U.S. Drug Prices — Here's What It Actually Means for You
Teva, CSL, Astellas, UCB and five other manufacturers have agreed to "most-favored-nation" pricing, bringing the total to 26 companies. The savings are real — but experts say most of them won't show up at your pharmacy counter just yet.
Sarcoidosis: When Inflammation Builds Tiny Clumps in the Body
Sarcoidosis is a disease in which the immune system forms small clusters of inflammatory cells — called granulomas — in one or more organs, most often the lungs. Its course is unpredictable: it can quietly fade on its own or become a long-term condition.
Prostate Cancer: Common, Often Slow, and Highly Treatable
Prostate cancer is one of the most common cancers in men — but it's also one of the most survivable. Many prostate cancers grow slowly and may never cause harm, while others need prompt treatment. Knowing the difference is what modern care is all about.
Obesity: Understanding a Complex Chronic Disease
Obesity is a chronic medical condition marked by excess body fat that can affect health. Modern medicine recognizes it as a disease shaped by genetics, biology, and environment — not a simple matter of willpower — and there are now more effective, compassionate ways to treat it than ever before.
Sickle Cell Disease: An Inherited Change in the Blood
Sickle cell disease is a genetic blood disorder that reshapes red blood cells into stiff crescents that block blood flow and break down too soon. It's a lifelong condition — but care has advanced dramatically, and the first curative therapies are now a reality.
Multiple Myeloma: A Cancer of the Blood's Antibody Factory
Multiple myeloma is a cancer of plasma cells — the immune cells in your bone marrow that make antibodies. When these cells grow out of control, they crowd out healthy blood cells and weaken bones. It's rarely curable, but today it's more treatable than ever.